Neurocrine Biosciences | I Saldi

Sales Cambiamento Data
AbbVie USD 12.31B 1.99B 2024-03
Acadia Pharmaceuticals USD 231.04M 19.34M 2023-12
Agios Pharmaceuticals USD 7.1M 296K 2023-12
ALKERMES USD 350.4M 27.08M 2024-03
Alnylam Pharmaceuticals USD 439.72M 310.81M 2023-12
Amgen USD 8.2B 1.29B 2023-12
Biogen USD 2.29B 96.3M 2024-03
BioMarin Pharmaceutical USD 649M 2.79M 2024-03
Cytokinetics USD 1.67M 1.29M 2023-12
Dynavax Technologies USD 55.6M 13.92M 2023-12
Exelixis USD 425M 54.65M 2024-03
Gilead Sciences USD 7.12B 64M 2023-12
Halozyme Therapeutics USD 230.04M 14.01M 2023-12
Incyte USD 880.89M 132.45M 2024-03
Intra Cellular Therapies USD 132.1M 5.93M 2023-12
Ionis Pharmaceuticals USD 325M 180.79M 2023-12
Neurocrine Biosciences USD 515.3M 100K 2024-03
Pfizer USD 14.9B 651M 2024-03
Prothena USD 316K 84.55M 2023-12
Regeneron Pharmaceuticals USD 3.43B 71.6M 2023-12
Repligen USD 151.3M 4.44M 2024-03
Sarepta Therapeutics USD 396.78M 64.96M 2023-12
Teva Pharmaceutical Industries USD 4.46B 607M 2023-12
Ultragenyx Pharmaceutical USD 127.39M 29.34M 2023-12
Vertex Pharmaceuticals USD 2.52B 34.2M 2023-12



Neurocrine Biosciences I Saldi - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2024.